Oslo - 30 January 2008 - NattoPharma has obtained a Food and Drug Administration (FDA) "Self affirmed GRAS" (Generally Recognized as Safe) approval for the use of MenaQ7/Vitamin K2 in the USA. "The GRAS approval will open new market opportunities with significant potential for revenue growth for the company in USA." says CEO Stein Westbye.

MenaQ7 is already approved as a food supplement in the USA and in use as an ingredient in different established brand. 

 

 

For more information, contact Morten Sundstø at +47 950 61 860 or email morten@sundsto.com

 

 

# # #

 

 

"MenaQ7" provides Natural Vitamin K2 as an extract of natto, a fermented soy food from Japan. Natto is particularly rich in the highly bio-available form of vitamin K2 called menaquinone-7 (MK-7).

"MenaQ7" provides the only commercially available Natural Vitamin K2 with guaranteed actives and stability, clinical substantiation and international patents awarded and pending.

 

For more information on the health benefits of MenaQ7, please visit www.menaq7.com

 

NattoPharma Norway is the exclusive international supplier of "MenaQ7", the natural Vitamin K2.

NattoPharma has entered into a multi-year research and development program to substantiate and discover the health benefits of natural vitamin K2 for applications in the exciting marketplace for functional food and health food supplements.

 

For more information about NattoPharma, please visit www.nattopharma.com